The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study
Title:
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study
Author:
Molinelli, Chiara Bruzzone, Marco Blondeaux, Eva Ruelle, Tommaso Lanzavecchia, Chiara De Laurentiis, Michelino Russo, Stefania Riccardi, Ferdinando Sini, Valentina Cognetti, Francesco Arpino, Grazia Fabi, Alessandra Pugliese, Palma CollovĂ , Elena Fontana, Andrea Puglisi, Fabio Bighin, Claudia Lambertini, Matteo Del Mastro, Lucia